Mr. Steven Wang is managing partner of HLC and a visting professor of Tsinghua University. He is former senior partner and investment committee member of CDH. He has nearly 20 years of experience in the medical industry and healthcare investment and focuses exclusively on healthcare services, medical device and pharmaceutical sectors. Prior to CDH, Mr. Wang served at Avenue Capital, Lehman Brothers (London) and Becton Dickinson Group. Over the last ten years, Mr. Wang was responsible for transactions totaling more than 1.5 billion dollars, including mergers & acquisitions, restructuring of publicly listed companies, growth and early stage investments.

Some of Mr. Wang’s representative deals include Mindray, Wuxi, Tigermed, Phamaron, Yuwell, United Imaging, Brightgene, Genetron Health, Kintor Pharmaceutical, Linwha, Sta, Sansure Biotech, Smoore etc.